SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-22-112462
Filing Date
2022-10-28
Accepted
2022-10-28 16:22:01
Documents
13
Period of Report
2022-07-20
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2229092d1_8k.htm   iXBRL 8-K/A 29652
2 EXHIBIT 99.1 tm2229092d1_ex99-1.htm EX-99.1 154733
  Complete submission text file 0001104659-22-112462.txt   369844

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA inva-20220720.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20220720_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20220720_pre.xml EX-101.PRE 22587
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2229092d1_8k_htm.xml XML 3606
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-30319 | Film No.: 221342207
SIC: 2834 Pharmaceutical Preparations